Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progressionLiza Cholin, Georges Nakhoul, Rémy Daou et al.|BMC Nephrology|2021Cited by 23
Proton-Pump Inhibitor vs. H2-Receptor Blocker Use and Overall Risk of CKD ProgressionLiza Cholin, Georges Nakhoul, Tarek Ashour et al.|Research Square|2020Cited by 1